658 related articles for article (PubMed ID: 9328287)
1. Expression of cytochrome P450 3A7 in Escherichia coli: effects of 5' modification and catalytic characterization of recombinant enzyme expressed in bicistronic format with NADPH-cytochrome P450 reductase.
Gillam EM; Wunsch RM; Ueng YF; Shimada T; Reilly PE; Kamataki T; Guengerich FP
Arch Biochem Biophys; 1997 Oct; 346(1):81-90. PubMed ID: 9328287
[TBL] [Abstract][Full Text] [Related]
2. Expression of modified cytochrome P450 2C10 (2C9) in Escherichia coli, purification, and reconstitution of catalytic activity.
Sandhu P; Baba T; Guengerich FP
Arch Biochem Biophys; 1993 Nov; 306(2):443-50. PubMed ID: 8215449
[TBL] [Abstract][Full Text] [Related]
3. Expression of cytochrome P450 3A5 in Escherichia coli: effects of 5' modification, purification, spectral characterization, reconstitution conditions, and catalytic activities.
Gillam EM; Guo Z; Ueng YF; Yamazaki H; Cock I; Reilly PE; Hooper WD; Guengerich FP
Arch Biochem Biophys; 1995 Mar; 317(2):374-84. PubMed ID: 7893152
[TBL] [Abstract][Full Text] [Related]
4. Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme.
Gillam EM; Baba T; Kim BR; Ohmori S; Guengerich FP
Arch Biochem Biophys; 1993 Aug; 305(1):123-31. PubMed ID: 8342945
[TBL] [Abstract][Full Text] [Related]
5. Construction of a human cytochrome P450 1A1: rat NADPH-cytochrome P450 reductase fusion protein cDNA and expression in Escherichia coli, purification, and catalytic properties of the enzyme in bacterial cells and after purification.
Chun YJ; Shimada T; Guengerich FP
Arch Biochem Biophys; 1996 Jun; 330(1):48-58. PubMed ID: 8651703
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase.
Dong MS; Yamazaki H; Guo Z; Guengerich FP
Arch Biochem Biophys; 1996 Mar; 327(1):11-9. PubMed ID: 8615680
[TBL] [Abstract][Full Text] [Related]
7. Coexpression of mammalian cytochrome P450 and reductase in Escherichia coli.
Dong J; Porter TD
Arch Biochem Biophys; 1996 Mar; 327(2):254-9. PubMed ID: 8619611
[TBL] [Abstract][Full Text] [Related]
8. Regulation of CYP3A9 gene expression by estrogen and catalytic studies using cytochrome P450 3A9 expressed in Escherichia coli.
Wang H; Strobel HW
Arch Biochem Biophys; 1997 Aug; 344(2):365-72. PubMed ID: 9264551
[TBL] [Abstract][Full Text] [Related]
9. Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5.
Shaw PM; Hosea NA; Thompson DV; Lenius JM; Guengerich FP
Arch Biochem Biophys; 1997 Dec; 348(1):107-15. PubMed ID: 9390180
[TBL] [Abstract][Full Text] [Related]
10. Bacterial expression and purification of the Arabidopsis NADPH-cytochrome P450 reductase ATR2.
Hull AK; Celenza JL
Protein Expr Purif; 2000 Apr; 18(3):310-5. PubMed ID: 10733884
[TBL] [Abstract][Full Text] [Related]
11. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.
Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T
Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495
[TBL] [Abstract][Full Text] [Related]
12. Drug metabolism by Escherichia coli expressing human cytochromes P450.
Parikh A; Gillam EM; Guengerich FP
Nat Biotechnol; 1997 Aug; 15(8):784-8. PubMed ID: 9255795
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of recombinant-expressed cytochrome P450 2C3 from Escherichia coli: 2C3 encodes the 6 beta-hydroxylase deficient form of P450 3b.
Richardson TH; Hsu MH; Kronbach T; Barnes HJ; Chan G; Waterman MR; Kemper B; Johnson EF
Arch Biochem Biophys; 1993 Jan; 300(1):510-6. PubMed ID: 8380971
[TBL] [Abstract][Full Text] [Related]
14. Stable expression of human cytochrome P450 3A4 in conjunction with human NADPH-cytochrome P450 oxidoreductase in V79 Chinese hamster cells.
Schneider A; Schmalix WA; Siruguri V; de Groene EM; Horbach GJ; Kleingeist B; Lang D; Böcker R; Belloc C; Beaune P; Greim H; Doehmer J
Arch Biochem Biophys; 1996 Aug; 332(2):295-304. PubMed ID: 8806738
[TBL] [Abstract][Full Text] [Related]
15. Biochemical characterization of lauric acid omega-hydroxylation by a CYP4A1/NADPH-cytochrome P450 reductase fusion protein.
Chaurasia CS; Alterman MA; Lu P; Hanzlik RP
Arch Biochem Biophys; 1995 Feb; 317(1):161-9. PubMed ID: 7872779
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites.
Avent KM; DeVoss JJ; Gillam EM
Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959
[TBL] [Abstract][Full Text] [Related]
17. Subcellular localization, aggregation state, and catalytic activity of microsomal P450 cytochromes modified in the NH2-terminal region and expressed in Escherichia coli.
Pernecky SJ; Olken NM; Bestervelt LL; Coon MJ
Arch Biochem Biophys; 1995 Apr; 318(2):446-56. PubMed ID: 7733676
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human cytochrome P450 1B1 expression in Escherichia coli.
Shimada T; Wunsch RM; Hanna IH; Sutter TR; Guengerich FP; Gillam EM
Arch Biochem Biophys; 1998 Sep; 357(1):111-20. PubMed ID: 9721189
[TBL] [Abstract][Full Text] [Related]
19. Escherichia coli expression and characterization of cytochromes P450 2B11, 2B1, and 2B5.
John GH; Hasler JA; He YA; Halpert JR
Arch Biochem Biophys; 1994 Nov; 314(2):367-75. PubMed ID: 7979377
[TBL] [Abstract][Full Text] [Related]
20. Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli.
Yamazaki H; Nakamura M; Komatsu T; Ohyama K; Hatanaka N; Asahi S; Shimada N; Guengerich FP; Shimada T; Nakajima M; Yokoi T
Protein Expr Purif; 2002 Apr; 24(3):329-37. PubMed ID: 11922748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]